Literature DB >> 19181342

Choice of hemostatic agent influences adhesion formation in a rat cecal adhesion model.

Nathan E Hoffmann1, Sameer A Siddiqui, Shvetank Agarwal, Stephen H McKellar, Harold J Kurtz, Matthew T Gettman, Mark H Ereth.   

Abstract

INTRODUCTION: Hemostatic agents are frequently used during abdominal surgery and some are linked to adhesion formation. We sought to evaluate the impact of several commonly used hemostatic agents on adhesion formation in a rat peritoneal model.
METHODS: In our study, Wister outbred rats underwent laparotomy and excision of a portion of their peritoneum to initiate adhesion formation process. One of six different hemostatic agents, namely, activated starch microspheres (Arista AH; Medafor Inc., Minneapolis, MN), glutaraldehyde activated collagen (BioGlue; Cryolife Inc., Kennesaw, GA), thrombin coated collagen microspheres (FloSeal; Baxter Inc., Deerfield, IL), thrombin activated fibrin polymer (Tisseel, Baxter), polyethylene glycol polymer (CoSeal, Baxter), or oxidized cellulose (Surgicel; Ethicon Inc., Somerville, NJ), was placed in the area of peritoneal defect. All animals were sacrificed on post-op day 7 and strength and extent of adhesion formation was determined. Histopathological examination of rat caecum was also performed.
RESULTS: Arista and CoSeal showed significantly lower adhesion formation than controls (P < 0.05). Higher adhesion scores were seen in BioGlue (P < 0.05) treated rats. Additionally, histopathologic examination showed that BioGlue caused statistically more inflammation and necrosis than controls (P < 0.05). Total adhesion score increased with residual amount of agent present at 7 d.
CONCLUSIONS: Use of Arista and CoSeal may help in reducing peritoneal adhesions after intra-abdominal surgeries. Furthermore, there appears to be a relationship between the creation of inflammation and necrosis in tissues and the eventual formation of adhesions. This could aid in improving the design of these agents in the future.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19181342     DOI: 10.1016/j.jss.2008.08.008

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  18 in total

Review 1.  Current strategies and future perspectives for intraperitoneal adhesion prevention.

Authors:  Christoph Brochhausen; Volker H Schmitt; Constanze N E Planck; Taufiek K Rajab; David Hollemann; Christine Tapprich; Bernhard Krämer; Christian Wallwiener; Helmut Hierlemann; Rolf Zehbe; Heinrich Planck; C James Kirkpatrick
Journal:  J Gastrointest Surg       Date:  2012-06       Impact factor: 3.452

2.  Natural orifice translumenal endoscopic surgery inguinal hernia repair: a survival canine model.

Authors:  Danny A Sherwinter; Amar Gupta; Jeremy G Eckstein
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2011-04       Impact factor: 1.878

3.  Treatment of de-peritonealized intestine with 4DryField® PH prevents adhesions between non-resorbable intra-peritoneal hernia mesh and bowel.

Authors:  Markus Winny; Lavinia Maegel; Leonie Victoria Grethe; Danny Jonigk; Paul Borchert; Alexander Kaltenborn; Harald Schrem; Juergen Klempnauer; Daniel Poehnert
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

4.  Laparoscopic fixation of biologic mesh at the hiatus with fibrin or polyethylene glycol sealant in a porcine model.

Authors:  Eric D Jenkins; Sopon Lerdsirisopon; Kevin P Costello; Lora Melman; Suellen C Greco; Margaret M Frisella; Brent D Matthews; Corey R Deeken
Journal:  Surg Endosc       Date:  2011-05-19       Impact factor: 4.584

Review 5.  Use of Monsel solution to treat obstetrical hemorrhage: a review and comparison to other topical hemostatic agents.

Authors:  Devin T Miller; Dana M Roque; Alessandro D Santin
Journal:  Am J Obstet Gynecol       Date:  2015-01-08       Impact factor: 8.661

6.  Biomimetic hybrid hydrogel for hemostasis, adhesion prevention and promoting regeneration after partial liver resection.

Authors:  Zuhong Li; Yalei Zhao; Xiaoxi Ouyang; Ya Yang; Yangjun Chen; Qixia Luo; Yanhong Zhang; Danhua Zhu; Xiaopeng Yu; Lanjuan Li
Journal:  Bioact Mater       Date:  2021-10-19

7.  Haemostatics in surgery and our experience in the enucleoresection of renal cell carcinoma.

Authors:  Gianna Pace; Pietro Saldutto; Carlo Vicentini; Lucio Miano
Journal:  World J Surg Oncol       Date:  2010-05-12       Impact factor: 2.754

8.  Does topical hemostatic agent (Floseal®) have a long-term adverse effect on erectile function recovery after nerve-sparing robot-assisted radical prostatectomy?

Authors:  Eugenio Martorana; Bernardo Rocco; Shaniko Kaleci; Giacomo Maria Pirola; Luigi Bevilacqua; Luca Reggiani Bonetti; Stefano Puliatti; Salvatore Micali; Giampaolo Bianchi
Journal:  Int Urol Nephrol       Date:  2017-07-04       Impact factor: 2.370

9.  Small bowel obstruction after FloSeal use.

Authors:  Benjamin Clapp; Antonio Santillan
Journal:  JSLS       Date:  2011 Jul-Sep       Impact factor: 2.172

10.  Use of a plant-based polysaccharide hemostat for the treatment of sternal bleeding after median sternotomy.

Authors:  Christoph Schmitz; Ralf Sodian
Journal:  J Cardiothorac Surg       Date:  2015-04-24       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.